Prime Medicine Inc PRME Q1 2026 Earnings WiderthanExpected Loss Highlights PreRevenue Development Phase INOD Q1 2026 Earnings EPS Smashes Estimates with 44688 Surprise VNO Q1 2026 Earnings EPS Misses Estimates as Office Sector Pressures Persist VNCE Q1 2026 Earnings Massive EPS Beat Surprises Market Despite Revenue Gap EW Q1 2026 Earnings EPS Beat Drives Stock Higher Amid Limited Revenue Disclosure CMPS Q1 2026 Earnings Loss Narrower Than Expected as Company Advances Clinical Pipeline